The weight-loss injection Wegovy is among the most profitable new prescribed drugs, however many individuals who need it could’t really entry it.
In most nations in Europe, Wegovy hasn’t but been launched, regardless of anticipated excessive demand. In the US, one of many few locations the place it’s obtainable, producer Novo Nordisk has been making an attempt to restrict the quantity of people that begin taking the drugs.
This isn’t the standard behaviour of a …
Source: www.newscientist.com